Aaron Killian

904 total citations
14 papers, 583 citations indexed

About

Aaron Killian is a scholar working on Infectious Diseases, Pharmacology and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Aaron Killian has authored 14 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 3 papers in Pharmacology and 3 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Aaron Killian's work include Antibiotics Pharmacokinetics and Efficacy (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Pneumocystis jirovecii pneumonia detection and treatment (2 papers). Aaron Killian is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Pneumocystis jirovecii pneumonia detection and treatment (2 papers). Aaron Killian collaborates with scholars based in United States. Aaron Killian's co-authors include Vikas Gupta, Marin H. Kollef, Ying P. Tabak, Larry Z. Liu, Andrew F. Shorr, Benjamin A. Lipsky, Michael Peng, John A. Weigelt, J. J. Kavanagh and D G Kieback and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Critical Care Medicine and The American Journal of Cardiology.

In The Last Decade

Aaron Killian

13 papers receiving 567 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aaron Killian United States 8 182 152 147 141 109 14 583
Goh Ohji Japan 13 153 0.8× 82 0.5× 192 1.3× 38 0.3× 56 0.5× 47 510
Nicholas Britt United States 12 298 1.6× 157 1.0× 208 1.4× 185 1.3× 64 0.6× 30 591
Peggy King United States 7 277 1.5× 142 0.9× 66 0.4× 173 1.2× 105 1.0× 10 551
Randall W. Strate United States 7 315 1.7× 100 0.7× 112 0.8× 179 1.3× 53 0.5× 12 556
Emile F. Schippers Netherlands 14 149 0.8× 74 0.5× 211 1.4× 33 0.2× 61 0.6× 45 701
Qiquan Wan China 15 85 0.5× 128 0.8× 272 1.9× 37 0.3× 33 0.3× 56 615
Pilar Luqué Spain 13 113 0.6× 111 0.7× 236 1.6× 46 0.3× 15 0.1× 42 701
Tara L. Anderson United States 14 398 2.2× 98 0.6× 176 1.2× 276 2.0× 104 1.0× 26 696
Sanna Gudmundsson Sweden 15 96 0.5× 189 1.2× 316 2.1× 27 0.2× 48 0.4× 31 910
Vrishali Lopes United States 15 67 0.4× 54 0.4× 182 1.2× 62 0.4× 104 1.0× 28 592

Countries citing papers authored by Aaron Killian

Since Specialization
Citations

This map shows the geographic impact of Aaron Killian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron Killian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron Killian more than expected).

Fields of papers citing papers by Aaron Killian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron Killian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron Killian. The network helps show where Aaron Killian may publish in the future.

Co-authorship network of co-authors of Aaron Killian

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron Killian. A scholar is included among the top collaborators of Aaron Killian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron Killian. Aaron Killian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Spak, Cedric W., Medhat Askar, Aaron Killian, et al.. (2021). ALVR109, an off-the-shelf partially HLA matched SARS-CoV-2–specific T cell therapy, to treat refractory severe COVID-19 pneumonia in a heart transplant patient: Case report. American Journal of Transplantation. 22(4). 1261–1265. 18 indexed citations
2.
Ghergurovich, Jonathan M., Jessica D. Lang, Maren K. Levin, et al.. (2021). Local production of lactate, ribose phosphate, and amino acids by human triple-negative breast cancer. Med. 2(6). 736–754.e6. 45 indexed citations
3.
4.
5.
Lipsky, Benjamin A., John A. Weigelt, Vikas Gupta, Aaron Killian, & Michael Peng. (2007). Skin, Soft Tissue, Bone, and Joint Infections in Hospitalized Patients: Epidemiology and Microbiological, Clinical, and Economic Outcomes. Infection Control and Hospital Epidemiology. 28(11). 1290–1298. 113 indexed citations
6.
Shorr, Andrew F., Ying P. Tabak, Aaron Killian, et al.. (2006). Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database*. Critical Care Medicine. 34(10). 2588–2595. 210 indexed citations
7.
Killian, Aaron, et al.. (2006). Cost Analysis of Erythropoietic-Stimulating Therapy Dosing in Oncology Inpatients. Annals of Pharmacotherapy. 40(3). 421–426. 6 indexed citations
8.
Luer, Mark S., et al.. (2004). Fluctuations in vancomycin CNS tissue concentrations following intermittent and continuous infusions in the rat. Neurological Research. 26(3). 312–315. 4 indexed citations
9.
Garey, Kevin W., Aaron Killian, P Narang, et al.. (1999). Penetration of rifabutin (R) into cerebrospinal fluid (CSF) of ventriculostomy patients. Clinical Pharmacology & Therapeutics. 65(2). 161–161. 1 indexed citations
10.
Erstad, Brian L., et al.. (1999). Survey of stress ulcer prophylaxis. Critical Care. 3(6). 145–149. 36 indexed citations
11.
Kanyok, Thomas P., Aaron Killian, Keith A. Rodvold, & Larry H. Danziger. (1997). Pharmacokinetics of intramuscularly administered aminosidine in healthy subjects. Antimicrobial Agents and Chemotherapy. 41(5). 982–986. 17 indexed citations
12.
Killian, Aaron. (1997). Measuring human immunodeficiency virus type 1 RNA viral load. American Journal of Health-System Pharmacy. 54(14). 1646–1651.
13.
Gotfried, Mark H., Aaron Killian, Ronald J. Servi, Larry H. Danziger, & Keith A. Rodvold. (1997). IV Cefuroxime Plus Oral Clarithromycin or IV Erythromycin for the Treatment of Community-Acquired Pneumonia in Hospitalised Patients. Clinical Drug Investigation. 14(1). 23–34. 2 indexed citations
14.
Kudelka, A P, Tally Levy, Claire F. Verschraegen, et al.. (1997). A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix.. PubMed. 3(9). 1501–5. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Goh Ohji Breakdown of academic impact, for papers by Nicholas Britt Breakdown of academic impact, for papers by Peggy King Breakdown of academic impact, for papers by Randall W. Strate Breakdown of academic impact, for papers by Emile F. Schippers Breakdown of academic impact, for papers by Qiquan Wan Breakdown of academic impact, for papers by Pilar Luqué Breakdown of academic impact, for papers by Tara L. Anderson Breakdown of academic impact, for papers by Sanna Gudmundsson Breakdown of academic impact, for papers by Vrishali Lopes
Rankless by CCL
2026